Abstract
186P Efficacy and safety of fruquintinib with nab-paclitaxel in advanced G/GEJ cancer after exposure to immune checkpoint inhibitors: A single-center prospective clinical trial
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have